We show that initial NRP1 expression is controlled by the level of TCR-engagement, that the protein remains expressed on tumor-specific CD8+ T cells in vivo and that NRP1 is found on a subset of tumor-specific CD8+ T cells in human ccRCC patients. This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.